申请人:On Target Laboratories, LLC
公开号:US20170066719A1
公开(公告)日:2017-03-09
The present disclosure relates to prostate specific membrane antigen (PSMA) targeted compounds conjugated to near-infra red (NIR) dyes and methods for their therapeutic and diagnostic use. More specifically, this disclosure provides compounds and methods for diagnosing and treating diseases associated with cells and/or vasculature expressing prostate specific membrane antigen (PSMA), such as prostate cancer and related diseases. The disclosure further describes methods and compositions for making and using the compounds, methods incorporating the compounds, and kits incorporating the compounds.
本公开涉及针对前列腺特异性膜抗原(PSMA)的靶向化合物,这些化合物与近红外(NIR)染料结合,并且涉及其治疗和诊断用途的方法。更具体地说,本公开提供了用于诊断和治疗与表达前列腺特异性膜抗原(PSMA)的细胞和/或血管相关的疾病,如前列腺癌和相关疾病的化合物和方法。本公开进一步描述了制备和使用这些化合物的方法和组成物,包括将这些化合物纳入方法中和将这些化合物纳入试剂盒中的方法。